Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Hypertension, Portal

3,4-dihydroxyphenylacetic acid has been researched along with Hypertension, Portal in 1 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Hypertension, Portal: Abnormal increase of resistance to blood flow within the hepatic PORTAL SYSTEM, frequently seen in LIVER CIRRHOSIS and conditions with obstruction of the PORTAL VEIN.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rodríguez-Puyol, D1
Alsasua, A1
Santos, JC1
Blanchart, A1
López-Novoa, JM1

Other Studies

1 other study available for 3,4-dihydroxyphenylacetic acid and Hypertension, Portal

ArticleYear
Plasma catecholamines and urinary excretion of their main metabolites in three models of portal hypertension.
    Clinical physiology and biochemistry, 1988, Volume: 6, Issue:6

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Catecholamines; Disease Models, Animal; Dopamine; Homovanil

1988